Dr. Nilanjan Ghosh
Claim this profileLevine Cancer Institute
Area of expertise
Lymphoma
Nilanjan Ghosh has run 5 trials for Lymphoma. Some of their research focus areas include:
Diffuse Large B-Cell Lymphoma
Nilanjan Ghosh has run 4 trials for Diffuse Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Carolinas Medical Center/Levine Cancer Institute
Levine Cancer Institute
Clinical Trials Nilanjan Ghosh is currently running
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting
2 awards
Phase 3
13 criteria
Post-CAR T-cell Therapy Drug Combo
for Non-Hodgkin's Lymphoma
This trial is testing two treatments, mosunetuzumab and polatuzumab vedotin, for patients with certain types of lymphoma that have come back or don't respond to other treatments. These treatments aim to stop cancer cells from growing or kill them directly. The goal is to see if these treatments can better control or shrink the cancer compared to not using them.
Recruiting
1 award
Phase 2
More about Nilanjan Ghosh
Clinical Trial Related
8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Nilanjan Ghosh has experience with
- Rituximab
- Mosunetuzumab
- Isavuconazole
- Acalabrutinib
- CC-95251
- Cetuximab
Breakdown of trials Nilanjan Ghosh has run
Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nilanjan Ghosh specialize in?
Nilanjan Ghosh focuses on Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved MYC positive patients, or patients who are BCL2 positive.
Is Nilanjan Ghosh currently recruiting for clinical trials?
Yes, Nilanjan Ghosh is currently recruiting for 3 clinical trials in Charlotte North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Nilanjan Ghosh has studied deeply?
Yes, Nilanjan Ghosh has studied treatments such as Rituximab, Mosunetuzumab, Isavuconazole.
What is the best way to schedule an appointment with Nilanjan Ghosh?
Apply for one of the trials that Nilanjan Ghosh is conducting.
What is the office address of Nilanjan Ghosh?
The office of Nilanjan Ghosh is located at: Levine Cancer Institute, Charlotte, North Carolina 28204 United States. This is the address for their practice at the Levine Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.